UK Renal Registry 14th Annual Report Figure 13.1. Consort diagram detailing incident RRT patients 2002–2006, HES admissions and ONS records included in.

Slides:



Advertisements
Similar presentations
UK Renal Registry 17th Annual Report Figure 5.1. Trend in one year after 90 day incident patient survival by first modality, 2003–2012 cohorts (adjusted.
Advertisements

UK Renal Registry 16th Annual Report Figure Data completeness for key variables, stratified by first modality HD = haemodialysis; PD = peritoneal.
UK Renal Registry 17th Annual Report Figure Data completeness for key variables, stratified by first modality DOB = date of birth; PRD = primary.
UK Renal Registry 15th Annual Report Figure One year death rate per 1,000 patient years by UK country and age group for prevalent dialysis.
UK Renal Registry 16th Annual Report Figure 5.1. Flow chart showing number of patients included in the various analyses.
UK Renal Registry 16th Annual Report Figure 8.1. Trend in 1 year after 90 day incident patient survival by first modality, 2005–2011 cohort (adjusted to.
Summary of the 2012 ERA-EDTA Registry Annual Report Amsterdam, the Netherlands, 2014.
UK Renal Registry 17th Annual Report Figure 9.1. Median height z-scores for transplant patients
UK Renal Registry 16th Annual Report Figure Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2012.
UK Renal Registry 14th Annual Report Figure 8.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2010.
UK Renal Registry 17th Annual Report Figure 8.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.
UK Renal Registry 17th Annual Report Figure 3.1. Transplant prevalence rate per million population by age and gender on 31/12/2013.
UKRR Annual Informatics Meeting, September 2013 Highlights from the 15 th Annual Report Rishi Pruthi Research Fellow UK Renal Registry.
UK Renal Registry 14th Annual Report Figure 3.1. Transplant prevalence rate per million population by age and gender on 31/12/2010.
UK Renal Registry 17th Annual Report Figure Percentage of patients waitlisted for a kidney transplant by renal centre, prior to or within two years.
Data completeness reporting Alex Hodsman, David Bull, Paul Dawson UK Renal Registry.
UK Renal Registry 17th Annual Report Figure 2.1. Prevalence rates per million population by age group and UK country on 31/12/2013.
UK Renal Registry 10th Annual Report 2007 Fig 3.1 Incident rates in the countries of the UK:
UK Renal Registry 17th Annual Report Figure 1.1. RRT incidence rates in the countries of the UK 1990–2013.
UK Renal Registry 10th Annual Report 2007 Fig 8.1 Median haemoglobin for incident dialysis patients at start of dialysis treatment.
UKRR – HES linkage James Fotheringham Sheffield Kidney Institute.
UK Renal Registry 15th Annual Report Figure 6.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2011.
UK Renal Registry 15th Annual Report Figure D.1. 95% confidence limits for incidence of 108 pmp for population size 80,000–800,000.
UK Renal Registry 17th Annual Report Figure Box and whisker plot of renal centres’ MRSA rates per 100 dialysis patient years by reporting year.
Summary of the 2013 ERA-EDTA Registry Annual Report Amsterdam, the Netherlands, 2015.
UK Renal Registry 16th Annual Report Figure Box and whisker plot of MRSA rates by renal centre per 100 prevalent dialysis patients per year by reporting.
UK Renal Registry 17th Annual Report Figure 4.1. RRT treatment used by prevalent paediatric patients
Introduction Data Statistical Methods Table 1: Prevalence of Prior Hip Fracture and Incidence of New Hip Fractures and Fractures of Any Type.
UK Renal Registry 13th Annual Report
UK Renal Registry 18th Annual Report
UK Renal Registry 10th Annual Report 2007
ANZDATA Registry 39th Annual Report Chapter 13: End Stage Kidney Disease in Aotearoa/New Zealand Data to 31-Dec-2015.
UK Renal Registry 15th Annual Report
Summary of the 2013 ERA-EDTA Registry Annual Report
South West Home Therapies Conference
UK Renal Registry 16th Annual Report
UK Renal Registry 18th Annual Report
UK Renal Registry 9th Annual Report 2006
UK Renal Registry 10th Annual Report 2007
UK Renal Registry 19th Annual Report
UK Renal Registry 13th Annual Report
UK Renal Registry 11th Annual Report
UK Renal Registry 11th Annual Report 2008
UK Renal Registry 13th Annual Report
Fig 6.1 Frequency of ischaemic heart disease in incident patients
UK Renal Registry 13th Annual Report
UK Renal Registry 11th Annual Report
Renal Association UK Renal Registry.
UK Renal Registry 15th Annual Report
UK Renal Registry 16th Annual Report
UK Renal Registry 16th Annual Report
UK Renal Registry 14th Annual Report
UK Renal Registry 16th Annual Report
UK Renal Registry 10th Annual Report 2007
UK Renal Registry 15th Annual Report
UK Renal Registry 14th Annual Report
UK Renal Registry 14th Annual Report
Renal Association UK Renal Registry.
UK Renal Registry 12th Annual Report
UK Renal Registry 14th Annual Report
UK Renal Registry 16th Annual Report
UK Renal Registry 14th Annual Report
Fig 7.1 Median URR achieved in each centre, 2006
UK Renal Registry 10th Annual Report 2007
UK Renal Registry 12th Annual Report
UK Renal Registry 13th Annual Report
UK Renal Registry 16th Annual Report
Renal Association UK Renal Registry.
UK Renal Registry 11th Annual Report
Renal Association UK Renal Registry.
Presentation transcript:

UK Renal Registry 14th Annual Report Figure Consort diagram detailing incident RRT patients 2002–2006, HES admissions and ONS records included in the analysis

UK Renal Registry 14th Annual Report Figure Mean diagnosis coding depth according to date of admission

UK Renal Registry 14th Annual Report Figure Funnel plot detailing the proportion of white incident patients in England by centre

UK Renal Registry 14th Annual Report Figure Late presentation over time determined from HES speciality coding for 38 centres with consistent HES coding between October 2003 and October 2006

UK Renal Registry 14th Annual Report Figure Prevalence of comorbid conditions at the time of starting RRT derived from UKRR and HES in 10,276 patients with data from both sources

UK Renal Registry 14th Annual Report Figure Mean comorbidity score by age group

UK Renal Registry 14th Annual Report Figure Mean comorbid score derived from HES according to year of start of RRT

UK Renal Registry 14th Annual Report Figure 13.8a. Mean comorbidity score per centre for patients surviving beyond 90 days, determined from UKRR comorbid conditions identified from admissions prior to starting RRT

Figure 13.8b. Mean comorbidity score per centre for patients surviving beyond 90 days stratified by RRT modality at 90 days, determined from UKRR comorbid conditions identified from admissions prior to starting RRT UK Renal Registry 14th Annual Report